Consolidated Statements of Cash Flows (Unaudited) - USD ($)	12 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2015
Cash Flows From Operating Activities:
Net income (loss)	$ 3,777,532	$ 666,503	$ (3,849,773)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and Amortization	486,024	507,446	768,165
Impairment of intangibles	0	0	1,495,703
Bad debt expense	345,700	68,140	186,780
Stock compensation expense	1,266,805	1,010,312	2,760,329
Charitable non-cash donations	0	0	157,950
Loss on short-term marketable securities	0	26,128	0
Gain on sale of fixed assets	(10,380)	0	0
Decrease (increase) in:
Trade Receivables	(2,325,075)	(1,975,517)	710,302
Prepaids and other assets	(1,257,534)	70,152	(501,957)
Increase (decrease) in:
Accounts payable	(14,822)	(236,810)	(49,296)
Accrued liabilities	355,136	(18,305)	136,517
Deferred revenue	(366,248)	385,174	(107,123)
Net cash provided by operating activities	2,257,138	503,223	1,707,597
Cash Flows From Investing Activities:
Cash from sale of marketable securities	0	4,612,908	0
Payments received on notes receivable	0	0	300,000
Net cash received in acquisition	0	0	22,119
Cash advanced on Note Receivable	0	0	(2,559,460)
Cash from sale of property and equipment	13,000	0	0
Purchase of property and equipment	(1,957,402)	(80,987)	(369,536)
Capitalization of software costs	0	(182,942)	0
Purchase of long-term investments	(6,300)	(75,584)	0
Purchase of marketable securities	0	(4,639,036)	0
Net cash used in investing activities	(1,950,702)	(365,641)	(2,606,877)
Cash Flows From Financing Activities:
Proceeds from employee stock plans	223,465	199,848	203,211
Proceeds from exercise of options and warrants	156,176	33,002	0
Proceeds from issuance of notes payable	1,824,617	0	172,795
Proceeds from issuance of stock	0	0	7,606,384
Net increase in lines of credit	350,000	0	1,300,000
Preferred stock redemption	0	0	(7,500)
Dividends paid	(10,576)	(10,575)	(157,147)
Payments on notes payable and capital leases	(239,500)	(242,041)	(245,450)
Net cash provided by (used in) financing activities	2,304,182	(19,766)	8,872,293
Net increase in cash and cash equivalents	2,610,618	117,816	7,973,013
Cash and cash equivalents at beginning of period	11,443,388	11,325,572	3,352,559
Cash and cash equivalents at end of period	14,054,006	11,443,388	11,325,572
Supplemental Disclosure of Cash Flow Information:
Cash paid for income taxes	66,163	0	0
Cash paid for interest	22,452	46,508	80,534
Supplemental Disclosure of Non-Cash Investing and Financing Activities:
Preferred stock to pay accrued liabilities	300,000	400,000	300,000
Common stock to pay accrued liabilities	783,457	1,687,741	1,860,191
Dividends accrued on preferred stock	790,811	729,288	568,821
Dividends paid with preferred stock	756,473	660,130	442,002
Series B restructure	0	0	2,141,980
Note payable for long-term investment	0	$ 396,000	0
Fair value of assets and liaiblities acquired:
Receivables	152,340		152,340
Prepaid expense	17,500		17,500
Customer relationships	1,314,000		1,314,000
Goodwill	16,077,953		16,077,953
Accounts payable	(128,126)		(128,126)
Deferred revenue	(598,232)		(598,232)
Net assets acquired	$ 16,835,435		$ 16,835,435
Common stock issued	10,821,897		10,821,897
Receivables eliminated in consolidation	$ 6,035,657		$ 6,035,657
Cash received in acquisition	$ 22,119		$ 22,119